Epigenetic priming of neuroblastoma to Natural Killer cell-based immunotherapy

神经母细胞瘤对基于自然杀伤细胞的免疫疗法的表观遗传启动

• 批准号: 489370
• 负责人: Raynal Noël J
• 金额: $ 59.07万
• 依托单位: Centre hospitalier universitaire Sainte-Justine (Montral, Qubec)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-09-01 至 2028-09-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=489370&lang=en
• 关键词: 3d Cell Culture; Epigenetics; Neuroblastoma; Nk Cells

Neuroblastoma is the most common extracranial solid tumour in children. Neuroblastoma arises from nerve cells, most often in the adrenal glands, or in other areas of the abdomen, the chest, the neck, and near the spine. Despite intensive treatments (surge

神经母细胞瘤是儿童中最常见的颅外实体瘤。神经母细胞瘤起源于神经细胞，最常见于肾上腺，或腹部、胸部、颈部和脊柱附近的其他区域。尽管进行了强化治疗（激增